Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Debt / NOTE 11/0
-
Market price (% of par)
-
91.13%
-
Total 13F principal
-
$546,867,200
-
Principal change
-
+$29,291,200
-
Total reported market value
-
$497,798,182
-
Number of holders
-
45
-
Value change
-
+$25,492,803
-
Number of buys
-
28
-
Number of sells
-
22
Institutional Holders of NOVOCURE LTD - NOTE 11/0 as of Q1 2022
As of 31 Mar 2022,
NOVOCURE LTD - NOTE 11/0 was held by
45 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$546,867,200
in principal (par value) of the bond.
The largest 10 bondholders included
WOLVERINE ASSET MANAGEMENT LLC, Allianz Asset Management GmbH, STEELHEAD PARTNERS LLC, DeepCurrents Investment Group LLC, Verition Fund Management LLC, D. E. Shaw & Co., Inc., BANK OF AMERICA CORP /DE/, CAPSTONE INVESTMENT ADVISORS, LLC, Balyasny Asset Management LLC, and Aequim Alternative Investments LP.
This page lists
45
institutional bondholders reporting positions
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.